HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $572,095,241 | +0.4% | 6,915,209 | +3.6% | 0.13% | -2.3% |
Q1 2024 | $569,689,998 | +2.1% | 6,674,751 | +2.3% | 0.13% | -5.8% |
Q4 2023 | $557,830,300 | -6.0% | 6,523,568 | -1.5% | 0.14% | -16.0% |
Q3 2023 | $593,301,598 | +4.2% | 6,623,148 | -1.0% | 0.16% | +6.5% |
Q2 2023 | $569,547,350 | +3.4% | 6,689,539 | +0.5% | 0.15% | -2.5% |
Q1 2023 | $550,597,151 | +17.5% | 6,653,742 | +11.7% | 0.16% | +10.6% |
Q4 2022 | $468,444,434 | +0.7% | 5,956,064 | -5.3% | 0.14% | -7.2% |
Q3 2022 | $465,373,000 | +13.7% | 6,286,276 | +0.1% | 0.15% | +19.5% |
Q2 2022 | $409,424,000 | +18.8% | 6,281,436 | +15.2% | 0.13% | +50.6% |
Q1 2022 | $344,676,000 | +217.1% | 5,452,006 | +166.1% | 0.08% | +254.2% |
Q4 2021 | $108,686,000 | +35.8% | 2,049,133 | +80.7% | 0.02% | +26.3% |
Q3 2021 | $80,031,000 | -55.2% | 1,133,748 | -57.7% | 0.02% | -54.8% |
Q2 2021 | $178,551,000 | -74.1% | 2,679,336 | -56.9% | 0.04% | -75.1% |
Q1 2021 | $690,204,000 | +3.1% | 6,217,498 | +10.3% | 0.17% | -2.9% |
Q4 2020 | $669,481,000 | +59.0% | 5,637,735 | +16.8% | 0.17% | +38.1% |
Q3 2020 | $421,026,000 | +17.9% | 4,825,515 | +21.0% | 0.13% | +11.5% |
Q2 2020 | $357,166,000 | +23.8% | 3,988,003 | +37.8% | 0.11% | 0.0% |
Q1 2020 | $288,396,000 | -6.9% | 2,893,800 | +7.4% | 0.11% | +21.5% |
Q4 2019 | $309,633,000 | -3.8% | 2,694,800 | +5.6% | 0.09% | -12.3% |
Q3 2019 | $321,783,000 | +4.8% | 2,551,000 | 0.0% | 0.11% | +9.3% |
Q2 2019 | $306,987,000 | +148.5% | 2,551,000 | +80.6% | 0.10% | +148.7% |
Q1 2019 | $123,535,000 | -12.6% | 1,412,150 | 0.0% | 0.04% | -20.4% |
Q4 2018 | $141,286,000 | -24.1% | 1,412,150 | -13.0% | 0.05% | -9.3% |
Q3 2018 | $186,078,000 | +27.8% | 1,624,000 | 0.0% | 0.05% | +35.0% |
Q2 2018 | $145,640,000 | +62.6% | 1,624,000 | +32.7% | 0.04% | +60.0% |
Q1 2018 | $89,548,000 | +336.2% | 1,224,000 | +246.3% | 0.02% | +316.7% |
Q4 2017 | $20,529,000 | – | 353,459 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |